Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Obesity

Free Subscription Articles published in Diabetes Care Retrieve available abstracts of 96 articles: HTML format

Single Articles

July 2026
1. GUAN Z, Stephan BCM, Siervo M
   Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank.
   Diabetes Care. 2026 Jul 13:dc260797. doi: 10.2337/dc26-0797.
   PubMed     Abstract available
   
   
   
2. ESPELAND MA, Semelka CT, Kritchevsky SB, Evans JK, et al
   The Look AHEAD Research Program: A 25-Year Retrospective From the Perspective of Geroscience.
   Diabetes Care. 2026;49:1159-1162.
   PubMed     Abstract available
   
   
   June 2026
3. JOHNSEN E, Bengtsson J, Halasa T, Lotfi A, et al
   Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study.
   Diabetes Care. 2026 Jun 8:dc260937. doi: 10.2337/dc26-0937.
   PubMed     Abstract available
   
   
   
4. MOORE JM, Kelsey MM
   Clinical Trial Design Considerations to Improve Equitable Anti-Obesity Medication Access for Youth.
   Diabetes Care. 2026;49:934-936.
   PubMed    
   
   
   
5. SCHUMACHER LM, Bauerle Bass S, Ard J, Rubin DJ, et al
   Response to Comment on Schumacher et al. Addressing the Feasibility Gap in Shared Decision-Making for Obesity and Type 2 Diabetes Care.
   Diabetes Care. 2026;49:e99-e100.
   PubMed    
   
   
   
6. RAGOZZINO G, Mattera E
   Comment on Schumacher et al. Shared Decision-Making Feasibility Gap in Obesity and Type 2 Diabetes Care.
   Diabetes Care. 2026;49:e98.
   PubMed    
   
   
   
7. CORRAO S
   Comment on Sattar et al. Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2. Diabetes Care 2025;48:e136-e137.
   Diabetes Care. 2026;49:e114-e115.
   PubMed    
   
   
   April 2026
8. FAN Y, Wu H, Lau ESH, Shi M, et al
   Associations of General Adiposity, Abdominal Adiposity and Their Changes With Fracture Risk in Chinese Individuals With Type 2 Diabetes: A Population-Based Cohort Study in Hong Kong.
   Diabetes Care. 2026 Apr 30:dc260261. doi: 10.2337/dc26-0261.
   PubMed     Abstract available
   
   
   
9. CURTO A, Konieczna J, Colom A, Abete I, et al
   Long-term Air Pollution and Overall and Regional Body Composition in Older Adults With Overweight or Obesity and Metabolic Syndrome.
   Diabetes Care. 2026 Apr 21:dc252497. doi: 10.2337/dc25-2497.
   PubMed     Abstract available
   
   
   
10. ALEXOPOULOS AS, Cusi K
    Integrating Alcohol Use Into MASLD Care: A Practical Guide for Diabetes and Obesity Care Teams.
    Diabetes Care. 2026 Apr 20:dci260019. doi: 10.2337/dci26-0019.
    PubMed     Abstract available
    
    
    
11. NAUCK M, Gribble F, Reimann F, D'Alessio DA, et al
    Clinical Potential of GIP in Type 2 Diabetes and Obesity.
    Diabetes Care. 2026 Apr 13:dci250141. doi: 10.2337/dci25-0141.
    PubMed     Abstract available
    
    
    
12. ROSEN VOLLMAR AK, Hedderson MM, Ngo AL, Chehab RF, et al
    Early Pregnancy Central Obesity and Risk of Prenatal and Postpartum Diabetes and Hypertensive Disorders.
    Diabetes Care. 2026 Apr 13:dc252812. doi: 10.2337/dc25-2812.
    PubMed     Abstract available
    
    
    March 2026
13. BAJAJ SS, Lin JC, Tandar CE, Stanford FC, et al
    Racial and Ethnic Differences Between Waist Circumference and BMI in Identifying Obesity.
    Diabetes Care. 2026 Mar 19:dc252214. doi: 10.2337/dc25-2214.
    PubMed    
    
    
    
14. CHEHAB RF, Greenberg MB, Lee C, Ngo AL, et al
    Gestational Diabetes, Glycemic Management Trajectories, and Offspring Growth Patterns and Obesity Risk.
    Diabetes Care. 2026 Mar 4:dc251643. doi: 10.2337/dc25-1643.
    PubMed     Abstract available
    
    
    
15. GANESHALINGAM AA, Uhrenholt N, Arnfred S, Gaede P, et al
    Semaglutide Effects on Insulin Sensitivity and beta-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial W
    Diabetes Care. 2026 Mar 4:dc252041. doi: 10.2337/dc25-2041.
    PubMed     Abstract available
    
    
    February 2026
16. PURNELL JQ, Marshall N, Francisco M, Leo M, et al
    Relationships Between Regional and Ectopic Adiposity and Insulin Sensitivity in Early and Late Pregnancy.
    Diabetes Care. 2026 Feb 26:dc252081. doi: 10.2337/dc25-2081.
    PubMed     Abstract available
    
    
    
17. VAN DER MEER R, Pazmino S, Steenackers N, van Laar A, et al
    Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study.
    Diabetes Care. 2026 Feb 18:dc252295. doi: 10.2337/dc25-2295.
    PubMed     Abstract available
    
    
    January 2026
18. BEALS JW, Smith GI, Farabi SS, Patterson BW, et al
    Sleep Extension Improves Sleep Health but Not Insulin Sensitivity in People With Overweight/Obesity Who Maintain Habitual Short Sleep Schedules.
    Diabetes Care. 2026 Jan 21:dc252083. doi: 10.2337/dc25-2083.
    PubMed     Abstract available
    
    
    
19. 
    8. Obesity and Weight Management for the Prevention and Treatment of Diabetes: Standards of Care in Diabetes-2026.
    Diabetes Care. 2026;49.
    PubMed     Abstract available
    
    
    
20. BELFORT-DEAGUIAR R, Yeckel CW, Elshafie A, Comarella AP, et al
    Association of Insulin Resistance and Insulin Secretion Indices and Glucose Metrics From Continuous Glucose Monitoring in People With Obesity.
    Diabetes Care. 2026;49:152-160.
    PubMed     Abstract available
    
    
    
21. LI L, Li R, Qiu Z, Zhu K, et al
    Prediction of Weight Loss and Regain Based on Multiomic and Phenotypic Features: Results From a Calorie-Restricted Feeding Trial.
    Diabetes Care. 2026;49:68-77.
    PubMed     Abstract available
    
    
    December 2025
22. KARAKUS KE, Akturk HK, Kruger D, Ahmann A, et al
    Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.
    Diabetes Care. 2025 Dec 22:dc252249. doi: 10.2337/dc25-2249.
    PubMed     Abstract available
    
    
    
23. JOSEFSON JL, King AS, Sun B, Quesenberry CP Jr, et al
    Midchildhood Obesity After Exposure to Gestational Diabetes Mellitus: The SWIFT Study in Youth.
    Diabetes Care. 2025 Dec 11:dc251093. doi: 10.2337/dc25-1093.
    PubMed     Abstract available
    
    
    
24. SCHUMACHER LM, Bass SB, Ard J, Rubin DJ, et al
    The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 Diabetes.
    Diabetes Care. 2025 Dec 3:dci250094. doi: 10.2337/dci25-0094.
    PubMed     Abstract available
    
    
    
25. LI C, Fan W
    Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342-1351.
    Diabetes Care. 2025;48:e180.
    PubMed    
    
    
    
26. SAMOVSKI D, Smith GI, Palacios H, Pietka T, et al
    Response to Comment on Samovski et al. Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes. Diabetes Care 2025;48:1342-1351.
    Diabetes Care. 2025;48:e181-e182.
    PubMed    
    
    
    November 2025
27. ARSLANIAN S, Gies I, Goldman B, Karlsson T, et al
    Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.
    Diabetes Care. 2025 Nov 26:dc250824. doi: 10.2337/dc25-0824.
    PubMed     Abstract available
    
    
    
28. SATTAR N, Buse JB
    Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care.
    Diabetes Care. 2025 Nov 14:dci250069. doi: 10.2337/dci25-0069.
    PubMed     Abstract available
    
    
    September 2025
29. LEE MMY, McGuire DK, Sattar N
    Response to Comment on Lee et al. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without
    Diabetes Care. 2025;48:e109-e110.
    PubMed    
    
    
    
30. CHANG YT, Lo SC, Kornelius E
    Comment on Lee et al. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabe
    Diabetes Care. 2025;48:e107-e108.
    PubMed    
    
    
    August 2025
31. SATTAR N, Fruhbeck G, Andreelli F, Garcia-Perez LE, et al
    Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2.
    Diabetes Care. 2025 Aug 21:dc251442. doi: 10.2337/dc25-1442.
    PubMed    
    
    
    
32. WU Z, Liu B, Li J, Zeleznik O, et al
    Plasma Metabolome, Long-term Body Weight Change, and Type 2 Diabetes in U.S. Individuals.
    Diabetes Care. 2025 Aug 13:dc250902. doi: 10.2337/dc25-0902.
    PubMed     Abstract available
    
    
    
33. LYTLE KA, Jensen MD
    Do Extracellular Vesicles Mediate the Muscle Insulin Resistance of Obesity and Type 2 Diabetes?
    Diabetes Care. 2025;48:1315-1317.
    PubMed    
    
    
    July 2025
34. BENSIGNOR MO, Hsia DS, Van Name MA, Jastreboff AM, et al
    Extinguishing the Fire: Treating Pediatric Type 2 Diabetes by Targeting Obesity Treatment.
    Diabetes Care. 2025 Jul 29:dci250031. doi: 10.2337/dci25-0031.
    PubMed     Abstract available
    
    
    
35. MARI A, Stefanski A, van Raalte DH, Ma X, et al
    Tirzepatide Treatment and Associated Changes in beta-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.
    Diabetes Care. 2025 Jul 22:dc250763. doi: 10.2337/dc25-0763.
    PubMed     Abstract available
    
    
    
36. PAGE B
    About the Editor: Naveed Sattar, MBChB, PhD-Reducing the Obesity Risk Factor and Management of Type 2 Diabetes.
    Diabetes Care. 2025;48:1056.
    PubMed    
    
    
    June 2025
37. BACONG AM, Njuguna V, Darbinian J, Rodriguez LA, et al
    High Prevalence of Prediabetes Among Asian and Pacific Islander Adolescents With Overweight or Obesity in a Primary Care Population.
    Diabetes Care. 2025 Jun 30:dc250343. doi: 10.2337/dc25-0343.
    PubMed     Abstract available
    
    
    
38. WONG HJ, Sim B, Teo YH, Dalakoti M, et al
    Response to Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Di
    Diabetes Care. 2025;48:e86-e87.
    PubMed    
    
    
    
39. HUANG J
    Comment on Wong et al. Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials. Diabetes Care
    Diabetes Care. 2025;48:e85.
    PubMed    
    
    
    April 2025
40. ARODA VR, Jorgensen NB, Kumar B, Lingvay I, et al
    High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial.
    Diabetes Care. 2025 Apr 25:dc242425. doi: 10.2337/dc24-2425.
    PubMed     Abstract available
    
    
    
41. SANDFORTH L, Raverdy V, Sandforth A, Bauvin P, et al
    Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes.
    Diabetes Care. 2025 Apr 11:dc250160. doi: 10.2337/dc25-0160.
    PubMed     Abstract available
    
    
    
42. SAMOVSKI D, Smith GI, Palacios H, Pietka T, et al
    Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes.
    Diabetes Care. 2025 Apr 10:dc242739. doi: 10.2337/dc24-2739.
    PubMed     Abstract available
    
    
    March 2025
43. RHEE TM, Kwak SH
    Response to Comment on Rhee et al. Genetic BMI and Diabetes: Unraveling the Complexities of Obesity and Metabolic Health.
    Diabetes Care. 2025;48:e37.
    PubMed    
    
    
    
44. LEE MMY, Ghouri N, Misra A, Kang YM, et al
    Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight
    Diabetes Care. 2025;48:489-493.
    PubMed     Abstract available
    
    
    February 2025
45. SIMONSON DC, Gourash WF, Arterburn DE, Hu B, et al
    Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study.
    Diabetes Care. 2025 Feb 4:dc242046. doi: 10.2337/dc24-2046.
    PubMed     Abstract available
    
    
    
46. WONG HJ, Sim B, Teo YH, Teo YN, et al
    Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials.
    Diabetes Care. 2025;48:292-300.
    PubMed     Abstract available
    
    
    January 2025
47. CAUSSY C, Verges B, Leleu D, Duvillard L, et al
    Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.
    Diabetes Care. 2025 Jan 31:dc242075. doi: 10.2337/dc24-2075.
    PubMed     Abstract available
    
    
    
48. D'ALESSIO DA, Kahn SE
    The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
    Diabetes Care. 2025;48:3-5.
    PubMed    
    
    
    
49. 
    8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed     Abstract available
    
    
    December 2024
50. NEUMILLER JJ, Bajaj M, Bannuru RR, McCoy RG, et al
    Compounded GLP 1 and Dual GIP/GLP 1 Receptor Agonists: A Statement from the American Diabetes Association.
    Diabetes Care. 2024 Dec 2:dci240091. doi: 10.2337/dci24-0091.
    PubMed     Abstract available
    
    
    November 2024
51. MITTENDORFER B, Patterson BW, Smith GI, Yoshino M, et al
    Effects of Obesity and Hyperglycemia on Postprandial Insulin-Mediated and Non-Insulin-Mediated Glucose Disposal.
    Diabetes Care. 2024 Nov 5:dc241280. doi: 10.2337/dc24-1280.
    PubMed     Abstract available
    
    
    October 2024
52. PUTRI RR, Casswall T, Danielsson P, Marcus C, et al
    Steatotic Liver Disease in Pediatric Obesity and Increased Risk for Youth-Onset Type 2 Diabetes.
    Diabetes Care. 2024 Oct 7:dc241236. doi: 10.2337/dc24-1236.
    PubMed     Abstract available
    
    
    
53. GROOTHOF D, Bais T, Bakker SJL
    Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371-378.
    Diabetes Care. 2024;47:e84.
    PubMed    
    
    
    
54. ZU C, Qin X
    Response to Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371-378.
    Diabetes Care. 2024;47:e85-e86.
    PubMed    
    
    
    
55. LOCATELLI JC, Costa JG, Haynes A, Naylor LH, et al
    Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
    Diabetes Care. 2024;47:1718-1730.
    PubMed     Abstract available
    
    
    September 2024
56. AXELROD CL, Hari A, Dantas WS, Kashyap SR, et al
    Metabolomic Fingerprints of Medical Therapy Versus Bariatric Surgery in Patients With Obesity and Type 2 Diabetes: The STAMPEDE Trial.
    Diabetes Care. 2024 Sep 23:dc240859. doi: 10.2337/dc24-0859.
    PubMed     Abstract available
    
    
    August 2024
57. RHEE TM, Choi J, Lee H, Merino J, et al
    Discrepancy Between Genetically Predicted and Observed BMI Predicts Incident Type 2 Diabetes.
    Diabetes Care. 2024 Aug 13:dc240879. doi: 10.2337/dc24-0879.
    PubMed     Abstract available
    
    
    June 2024
58. LINGVAY I, Deanfield J, Kahn SE, Weeke PE, et al
    Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.
    Diabetes Care. 2024 Jun 22:dc240764. doi: 10.2337/dc24-0764.
    PubMed     Abstract available
    
    
    
59. KAHN SE, Deanfield JE, Jeppesen OK, Emerson SS, et al
    Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.
    Diabetes Care. 2024 Jun 22:dc240491. doi: 10.2337/dc24-0491.
    PubMed     Abstract available
    
    
    
60. DRUCKER DJ
    Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.
    Diabetes Care. 2024 Jun 6:dci240003. doi: 10.2337/dci24-0003.
    PubMed     Abstract available
    
    
    May 2024
61. PANE A, Videla L, Calvet A, Viaplana J, et al
    Hypothalamic Inflammation Improves Through Bariatric Surgery, and Hypothalamic Volume Predicts Short-Term Weight Loss Response in Adults With or Without Type 2 Diabetes.
    Diabetes Care. 2024 May 7:dc232213. doi: 10.2337/dc23-2213.
    PubMed     Abstract available
    
    
    April 2024
62. LI M, Li J, Xu Y, Gao J, et al
    Effect of 5:2 Regimens: Energy-Restricted Diet or Low-Volume High-Intensity Interval Training Combined With Resistance Exercise on Glycemic Control and Cardiometabolic Health in Adults With Overweight/Obesity and Type 2 Diabetes-A Three-Arm Randomized
    Diabetes Care. 2024 Apr 18:dc240241. doi: 10.2337/dc24-0241.
    PubMed     Abstract available
    
    
    
63. SABAG A, Ahmadi MN, Francois ME, Postnova S, et al
    Timing of Moderate to Vigorous Physical Activity, Mortality, Cardiovascular Disease, and Microvascular Disease in Adults With Obesity.
    Diabetes Care. 2024 Apr 10:dc232448. doi: 10.2337/dc23-2448.
    PubMed     Abstract available
    
    
    
64. KAWADA T
    Comment on Zuraikat et al. Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial. Diabetes Care 2024;47:117-125.
    Diabetes Care. 2024;47:e36.
    PubMed    
    
    
    
65. ST-ONGE MP, Zuraikat FM, Laferrere B, Jelic S, et al
    Response to Comment on Zuraikat et al. Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial. Diabetes Care 2024;47:117-125.
    Diabetes Care. 2024;47:e37-e38.
    PubMed    
    
    
    March 2024
66. NAGEL KE, Ramachandran R, Lipska KJ
    Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.
    Diabetes Care. 2024 Mar 27:dci230042. doi: 10.2337/dci23-0042.
    PubMed     Abstract available
    
    
    February 2024
67. SATTAR N, Presslie C, Rutter MK, McGuire DK, et al
    Cardiovascular and Kidney Risks in Individuals With Type 2 Diabetes: Contemporary Understanding With Greater Emphasis on Excess Adiposity.
    Diabetes Care. 2024 Feb 27:dci230041. doi: 10.2337/dci23-0041.
    PubMed     Abstract available
    
    
    January 2024
68. PALERMO BJ, Wilkinson KS, Plante TB, Nicoli CD, et al
    Interleukin-6, Diabetes, and Metabolic Syndrome in a Biracial Cohort: The Reasons for Geographic and Racial Differences in Stroke Cohort.
    Diabetes Care. 2024 Jan 18:dc230914. doi: 10.2337/dc23-0914.
    PubMed     Abstract available
    
    
    
69. FOLON L, Baron M, Scherrer V, Toussaint B, et al
    Pathogenic, Total Loss-of-Function DYRK1B Variants Cause Monogenic Obesity Associated With Type 2 Diabetes.
    Diabetes Care. 2024 Jan 3:dc231851. doi: 10.2337/dc23-1851.
    PubMed     Abstract available
    
    
    
70. 
    8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024.
    Diabetes Care. 2024;47.
    PubMed     Abstract available
    
    
    
71. JOSEFSON JL
    It's All About Fat, Baby: Is Infant Adiposity Associated With Later Adverse Metabolic Health?
    Diabetes Care. 2024;47:44-46.
    PubMed    
    
    
    December 2023
72. ZU C, Liu M, Su X, Wei Y, et al
    Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus.
    Diabetes Care. 2023 Dec 11:dc231727. doi: 10.2337/dc23-1727.
    PubMed     Abstract available
    
    
    
73. WANG HH, Chong M, Perrot N, Feiner J, et al
    Vaspin: A Novel Biomarker Linking Gluteofemoral Body Fat and Type 2 Diabetes Risk.
    Diabetes Care. 2023 Dec 6:dc231488. doi: 10.2337/dc23-1488.
    PubMed     Abstract available
    
    
    
74. KHUNTI K, Chudasama YV, Gregg EW, Kamkuemah M, et al
    Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge.
    Diabetes Care. 2023;46:2092-2101.
    PubMed     Abstract available
    
    
    
75. KOYAMA AK, Bullard KM, Onufrak S, Xu F, et al
    Risk Factors Amenable to Primary Prevention of Type 2 Diabetes Among Disaggregated Racial and Ethnic Subgroups in the U.S.
    Diabetes Care. 2023;46:2112-2119.
    PubMed     Abstract available
    
    
    November 2023
76. ZURAIKAT FM, Laferrere B, Cheng B, Scaccia SE, et al
    Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes: Results of a Randomized Trial.
    Diabetes Care. 2023 Nov 13:dc231156. doi: 10.2337/dc23-1156.
    PubMed     Abstract available
    
    
    
77. OTT R, Stein R, Hauta-Alus HH, Ronkainen J, et al
    Epigenome-Wide Meta-analysis Reveals Associations Between Dietary Glycemic Index and Glycemic Load and DNA Methylation in Children and Adolescents of Different Body Sizes.
    Diabetes Care. 2023;46:2067-2075.
    PubMed     Abstract available
    
    
    October 2023
78. TRIPYLA A, Ferreira A, Schonenberger KA, Naf NH, et al
    Relationship Between Symptom Perception and Postprandial Glycemic Profiles in Patients With Postbariatric Hypoglycemia After Roux-en-Y Gastric Bypass Surgery.
    Diabetes Care. 2023;46:1792-1798.
    PubMed     Abstract available
    
    
    September 2023
79. LI X, Shao X, Kou M, Wang X, et al
    DNA Methylation at ABCG1 and Long-Term Changes in Adiposity and Fat Distribution in Response to Dietary Interventions: The POUNDS Lost Trial.
    Diabetes Care. 2023 Sep 28:dc230748. doi: 10.2337/dc23-0748.
    PubMed     Abstract available
    
    
    August 2023
80. HERNANDEZ TL, Farabi SS, Fosdick BK, Hirsch N, et al
    Randomization to a Provided Higher-Complex-Carbohydrate Versus Conventional Diet in Gestational Diabetes Results in Similar Maternal 24-Hour Glycemia and Newborn Adiposity.
    Diabetes Care. 2023 Aug 29:dc230617. doi: 10.2337/dc23-0617.
    PubMed     Abstract available
    
    
    
81. MANERKAR K, Crowther CA, Harding JE, Meyer MP, et al
    Impact of Gestational Diabetes Detection Thresholds on Infant Growth and Body Composition: A Prospective Cohort Study Within a Randomized Trial.
    Diabetes Care. 2023 Aug 29:dc230464. doi: 10.2337/dc23-0464.
    PubMed     Abstract available
    
    
    
82. ZACCARDI F, Ling S, Brown K, Davies M, et al
    Duration of Type 2 Diabetes and Incidence of Cancer: An Observational Study in England.
    Diabetes Care. 2023 Aug 28:dc231013. doi: 10.2337/dc23-1013.
    PubMed     Abstract available
    
    
    June 2023
83. BROWN OI, Drozd M, McGowan H, Giannoudi M, et al
    Relationship Among Diabetes, Obesity, and Cardiovascular Disease Phenotypes: A UK Biobank Cohort Study.
    Diabetes Care. 2023 Jun 27:dc230294. doi: 10.2337/dc23-0294.
    PubMed     Abstract available
    
    
    
84. VAN POPPEL MNM, Damm P, Mathiesen ER, Ringholm L, et al
    Is the Biphasic Effect of Diabetes and Obesity on Fetal Growth a Risk Factor for Childhood Obesity?
    Diabetes Care. 2023;46:1124-1131.
    PubMed     Abstract available
    
    
    
85. WANG G, Radovick S, Buckley JP, Hauser R, et al
    Plasma Insulin Concentration in Newborns and Children and Age at Menarche.
    Diabetes Care. 2023;46:1231-1238.
    PubMed     Abstract available
    
    
    
86. MITTENDORFER B, Patterson BW, Haire-Joshu D, Cahill AG, et al
    Insulin Sensitivity and beta-Cell Function During Early and Late Pregnancy in Women With and Without Gestational Diabetes Mellitus.
    Diabetes Care. 2023 Jun 1:dc221894. doi: 10.2337/dc22-1894.
    PubMed     Abstract available
    
    
    May 2023
87. QIAN J, Xiao Q, Walkup MP, Coday M, et al
    Association of Timing of Moderate-to-Vigorous Physical Activity With Changes in Glycemic Control Over 4 Years in Adults With Type 2 Diabetes From the Look AHEAD Trial.
    Diabetes Care. 2023 May 25:dc222413. doi: 10.2337/dc22-2413.
    PubMed     Abstract available
    
    
    
88. FRANKS PW
    Socioeconomic Disparities Across the Spectrum of Genetic Burden in Type 2 Diabetes and Obesity Risk.
    Diabetes Care. 2023;46:916-917.
    PubMed    
    
    
    March 2023
89. LIAO Z, Xie X, Wang J, Chen Y, et al
    Impact of Early Life Factors on Metabolic Phenotypes of Obesity in Preschool Children.
    Diabetes Care. 2023 Mar 16:dc221851. doi: 10.2337/dc22-1851.
    PubMed     Abstract available
    
    
    
90. NABILA S, Kim JE, Choi J, Park J, et al
    Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes.
    Diabetes Care. 2023;46:535-543.
    PubMed     Abstract available
    
    
    
91. STENTEBJERG LL, Madsen LR, Stoving RK, Andersen LLT, et al
    Roux-en-Y Gastric Bypass Increases Glycemic Excursions During Pregnancy and Postpartum: A Prospective Cohort Study.
    Diabetes Care. 2023;46:502-510.
    PubMed     Abstract available
    
    
    
92. HEISE T, DeVries JH, Urva S, Li J, et al
    Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
    Diabetes Care. 2023 Mar 1:dc221710. doi: 10.2337/dc22-1710.
    PubMed     Abstract available
    
    
    February 2023
93. ADESOBA TP, Brown CC
    Trends in the Prevalence of Lean Diabetes Among U.S. Adults, 2015-2020.
    Diabetes Care. 2023 Feb 10:dc221847. doi: 10.2337/dc22-1847.
    PubMed     Abstract available
    
    
    January 2023
94. STRAIN T, Dempsey PC, Wijndaele K, Sharp SJ, et al
    Quantifying the Relationship Between Physical Activity Energy Expenditure and Incident Type 2 Diabetes: A Prospective Cohort Study of Device-Measured Activity in 90,096 Adults.
    Diabetes Care. 2023 Jan 24:dc221467. doi: 10.2337/dc22-1467.
    PubMed     Abstract available
    
    
    
95. MCPHERSON AR, Bancks MP
    Assessment for Gender Differences in Trend in Age at Diagnosis of Diabetes Among U.S. Adults, 1999-2020.
    Diabetes Care. 2023 Jan 11:dc221572. doi: 10.2337/dc22-1572.
    PubMed    
    
    
    December 2022
96. VAJRAVELU ME, Mani I, Malik S, Hewitt B, et al
    Race and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and Body Mass Index in Youth With Diabetes.
    Diabetes Care. 2022 Dec 19:dc221439. doi: 10.2337/dc22-1439.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum